Inhibiting the P2Y13 receptor reduces IL-33 and HMGB1 lung concentrations and inflammatory cell infiltration in a murine model of asthma

被引：0

作者：

Lanxin Li

Stephen J. Fuller

机构：

[1] University of Sydney,Department of Medicine, Sydney Medical School Nepean

[2] Nepean Hospital,undefined

来源：

Purinergic Signalling | 2022年 / 18卷

关键词：

D O I：

暂无

中图分类号：

学科分类号：

摘要：

引用

页码：403 / 405

页数：2

共 15 条

[1] Inhibiting the P2Y13 receptor reduces IL-33 and HMGB1 lung concentrations and inflammatory cell infiltration in a murine model of asthma
Li, Lanxin
Fuller, Stephen J.
PURINERGIC SIGNALLING, 2022, 18 (04) : 403 - 405
[2] Targeting the P2Y13 Receptor Suppresses IL-33 and HMGB1 Release and Ameliorates Experimental Asthma
Werder, Rhiannon B.
Ullah, Md Ashik
Rahman, Muhammed Mahfuzur
Simpson, Jennifer
Lynch, Jason P.
Collinson, Natasha
Rittchen, Sonja
Rashid, Ridwan B.
Sikder, Md Al Amin
Handoko, Herlina Y.
Curren, Bodie F.
Sebina, Ismail
Hartel, Gunter
Bissell, Alec
Ngo, Sylvia
Yarlagadda, Tejasri
Hasnain, Sumaira Z.
Lu, Wenying
Sohal, Sukhwinder S.
Martin, Megan
Bowler, Simon
Burr, Lucy D.
Martinez, Laurent O.
Robaye, Bernard
Spann, Kirsten
Ferreira, Manuel A. R.
Phipps, Simon
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2022, 205 (03) : 300 - 312
[3] Mechanism of action of miR-15b-5p in alleviating asthma airway remodeling through the HMGB1/TLR4/IL-33 signaling axis
Liu, Wanting
Li, Liangchang
Piao, Yihua
Wang, Zhiguang
Dai, Longzhu
Li, Yan
Piao, Hongmei
Song, Yilan
Cui, Qingsong
Wang, Chongyang
Yan, Guanghai
INTERNATIONAL IMMUNOPHARMACOLOGY, 2025, 145
[4] Regulation of the IL-33/ST2 pathway contributes to the anti-inflammatory effect of acupuncture in the ovalbumin-induced murine asthma model
Dong, Ming
Ma, Cheng
Wang, Wen-Qian
Chen, Juan
Wei, Ying
ACUPUNCTURE IN MEDICINE, 2018, 36 (05) : 319 - 326
[5] IL-1β enhances vascular smooth muscle cell proliferation and migration via P2Y2 receptor-mediated RAGE expression and HMGB1 release
Eun, So Young
Ko, Young Shin
Park, Sang Won
Chang, Ki Churl
Kim, Hye Jung
VASCULAR PHARMACOLOGY, 2015, 72 : 108 - 117
[6] Experimental asthma persists in IL-33 receptor knockout mice because of the emergence of thymic stromal lymphopoietin-driven IL-9+ and IL-13+ type 2 innate lymphoid cell subpopulations
Verma, Mukesh
Liu, Sucai
Michalec, Lidia
Sripada, Anand
Gorska, Magdalena M.
Alam, Rafeul
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2018, 142 (03) : 793 - +
[7] A new cell pathway to regulate hepatic HDL endocytosis:: Involvement of ecto-F1-ATPase, purinergic receptor P2Y13 and Rho kinase
Malaval, C.
Jacquet, J.
Martinez, L. O.
Rolland, C.
Terce, F.
Collet, X.
Barbaras, R.
ATHEROSCLEROSIS SUPPLEMENTS, 2006, 7 (03) : 153 - 153
[8] Histamine 4 Receptor Antagonism modulates TH2 cell function, IL13 production, and lung remodeling in a model of chronic asthma
Cowden, Jeffery
Riley, Jason
Thurmond, Robin
Dunford, Paul J.
FASEB JOURNAL, 2008, 22
[9] Glucagon-like peptide 1 signaling inhibits allergen-induced lung IL-33 release and reduces group 2 innate lymphoid cell cytokine production in vivo
Toki, Shinji
Goleniewska, Kasia
Reiss, Sara
Zhang, Jian
Bloodworth, Melissa H.
Stier, Matthew T.
Zhou, Weisong
Newcomb, Dawn C.
Ware, Lorraine B.
Stanwood, Gregg D.
Galli, Aurelio
Boyd, Kelli L.
Niswender, Kevin D.
Peebles, R. Stokes, Jr.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2018, 142 (05) : 1515 - +
[10] A CpG-Oligodeoxynucleotide Suppresses Th2/Th17 Inflammation by Inhibiting IL-33/ST2 Signaling in Mice from a Model of Adoptive Dendritic Cell Transfer of Smoke-Induced Asthma
Yang, Xuena
Su, Beiting
Liu, Jing
Zheng, Li
Tao, Peizhi
Lin, Yusen
Zou, Xiaoling
Yang, Hailing
Wu, Wenbin
Meng, Ping
Zhang, Tiantuo
Li, Hongtao
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2023, 24 (04)

← 1 2 →